Exploratory analysis shows impact of hvem and pd-l1 on progression-free survival in advanced lung cancer, suggesting a potential treatment pathway.
Supplementary Figure 5. The exploratory analysis of PFS according to HVEM and PD-L1 expression.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: